PerkinElmer Inc (PKI)-医療機器分野:企業M&A・提携分析

◆英語タイトル:PerkinElmer Inc (PKI) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010928
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:91
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PerkinElmer Inc (PerkinElmer) is a provider of detection, imaging, and informatics solutions and services to diagnostics, research, laboratory services, environmental, and industrial markets. The company’s product portfolio comprises lab products and services; imaging components; diagnostic services for clinicians and families; and cord blood and tissue banking services. It also offers technologies for detection and identification of disease, contaminants, and biological pathways; imaging technologies for recording biological, cellular, and treatment events; and software platforms and informatics for data management, visualization, analytics, efficient workflow. PerkinElmer’s products find applications in early detection of genetic disorders, infectious disease testing, diagnosis of metabolic disorders, cancer treatment, drug discovery and other research activities. Its service offerings include analytics, compliance, contract research, custom research, genetic screening, instrumentation, prenatal screening, information, and scientific services. PerkinElmer is headquartered in Waltham, Massachusetts, US.

PerkinElmer Inc (PKI) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 6
PerkinElmer Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 7
PerkinElmer Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 8
PerkinElmer Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 9
PerkinElmer Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 10
PerkinElmer Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 11
PerkinElmer Inc, Medical Equipment, Deal Details 13
Partnerships 13
Applied BioCode Expands Licensing Agreement with PerkinElmer for Barcoded Magnetic Bead Technology 13
PerkinElmer Expands Licensing Agreement With Tibco Software 14
PerkinElmer Enters Into Licensing Agreement With Tibco Software For Tibco Spotfire 15
PerkinElmer Enters Into Licensing Agreement With GenMark Diagnostics For Microfluidics Patent Portfolio 16
Fluidigm Amends Licensing Agreement with Caliper Life Sciences 17
Mobidiag Expand Agreement with Wallac 18
10X Genomics Enters into Agreement with PerkinElmer 19
OncoSec Medical Enters into Research Agreement with University of California and PerkinElmer 20
Sofie Biosciences and PerkinElmer Extends Partnership 21
PerkinElmer Enters into Distribution Agreement with Sebia 22
Good Start Genetics Enters Into Agreement With PerkinElmer To Provide GoodStart Select Carrier Screening Tests 23
Transgenomic Enters Into Co-Marketing Agreement With PerkinElmer For Oncology Diagnostic Test Portfolio 24
ViaCord Enters Into Agreement With Center for International Blood and Marrow Transplant Research For Stem Cell Therapy Research 25
TrovaGene Enters Into R&D Agreement With PerkinElmer Health Sciences 26
PerkinElmer Enters Into Agreement With National Center for Drug Screening 27
PerkinElmer Enters Into Co-Marketing Agreement With Verinata Health For Verifi Test 28
Perkinelmer Enters Into Co-Development Agreement With Massachusetts General Hospital 29
Integromics Enters Into Co-Development Agreement With Galician Foundation Of Genomic Medicine 30
DxTerity Diagnostics Enters Into Technology Integration Agreement With Caliper Life Sciences 31
PerkinElmer Enters Into Distribution Agreement With Rubicon Genomics 32
Roche Enters Into Distribution Agreement With PerkinElmer 33
Roche NimbleGen Enters Into Co-Marketing Agreement With Caliper Life Sciences 34
Caliper Life Sciences Enters Into Co-Development Agreement With HistoRx 35
Caliper Life Sciences Enters Into Co-Marketing Agreement With Covaris 36
PerkinElmer Enters Into Co-Development Agreement With Meyer Children’s Hospital of Florence 37
Caliper Life Sciences Enters Into An Agreement With Seegene 38
Equity Offering 39
PerkinElmer Plans to Spin Out Diagnostics Business 39
Debt Offering 40
PerkinElmer Raises USD552.3 Million in Public Offering of 1.875% Senior Notes Due 2026 40
PerkinElmer Completes Private Placement Of 5% Senior Notes Due 2021 For US$500 Million 42
Asset Transactions 44
Varex Imaging Acquires Medical Imaging Business of PerkinElmer 44
Acquisition 45
PerkinElmer to Acquire Tulip Diagnostics 45
PerkinElmer Acquires Vanadis Diagnostics 46
PerkinElmer Acquires Shanghai Haoyuan Biotech From Medigen Biotech For US$38 Million 47
PerkinElmer Completes Acquisition Of Caliper Life Sciences For US$600 Million 49
PerkinElmer Acquires Dexela 51
PerkinElmer Acquires Labtronics 52
PerkinElmer Acquires Geospiza 53
PerkinElmer Acquires Chemagen Biopolymer 54
PerkinElmer Inc – Key Competitors 56
PerkinElmer Inc – Key Employees 57
PerkinElmer Inc – Locations And Subsidiaries 58
Head Office 58
Other Locations & Subsidiaries 58
Joint Venture 62
Recent Developments 63
Strategy And Business Planning 63
Sep 21, 2017: State Key Laboratory of Biochemical Engineering and PerkinElmer Open Joint Translational Medical Engineering Demonstration Laboratory in Beijing 63
Sep 26, 2016: PerkinElmer Announces New Organizational Structure 64
Financial Announcements 65
Nov 02, 2017: PerkinElmer Announces Financial Results for the Third Quarter of 2017 65
Aug 03, 2017: PerkinElmer Announces Financial Results for the Second Quarter of 2017 66
May 04, 2017: PerkinElmer Announces Financial Results for the First Quarter of 2017 67
Feb 02, 2017: PerkinElmer Announces Financial Results for Fourth Quarter and Full Year 2016 68
Nov 07, 2016: PerkinElmer Announces Financial Results for the Third Quarter of 2016 70
Aug 04, 2016: PerkinElmer Announces Financial Results for the Second Quarter of 2016 71
May 05, 2016: PerkinElmer Announces Financial Results for the First Quarter of 2016 72
Feb 04, 2016: PerkinElmer Announces Financial Results for Fourth Quarter and Full Year 2015 73
Corporate Communications 75
Oct 30, 2017: PerkinElmer Elects Pascale Witz to its Board of Directors 75
Sep 15, 2017: PerkinElmer Announces Future Retirement of Andy Wilson, Chief Financial Officer 76
Oct 17, 2016: PerkinElmer Elects Samuel Chapin to Board of Directors 77
Jul 27, 2016: PerkinElmer Elects Frank Witney to Board of Directors 78
Product News 79
Apr 03, 2017: New Cloud-Based PerkinElmer Signals Notebook Helps Scientists Accelerate Drug Discovery Research 79
Mar 23, 2017: PerkinElmer to Display Portfolio of Cancer Research Technologies and Workflow Solutions at 2017 AACR Annual Meeting 80
Jan 26, 2017: PerkinElmer Launches Vectra Polaris Automated Quantitative Pathology Imaging System 82
May 04, 2016: PerkinElmer and Covaris offer next gen sequencing grade nucleic acid purification and automated sample prep from FFPE tissue samples 83
Apr 20, 2016: New Research Published in the New England Journal of Medicine Reveals High Response Rates to Anti-PD1 Therapeutics in Merkel Cell Carcinoma 84
Other Significant Developments 85
Sep 14, 2017: PerkinElmer and in-Depth Genomics Team Up for Whole Genome Sequencing Diagnostic Program for Rare Diseases 85
Aug 03, 2017: PerkinElmer Launches Clinical Whole Genome Sequencing Services 86
May 30, 2017: Mobidiag Extends Distribution Agreement with PerkinElmer to Offer Amplidiag Diagnostics Products in African Countries and Israel 87
Mar 08, 2017: HISTALIM is The First European Laboratory to Adopt the Vectra Polaris Automated Quantitative Pathology Imaging System Developed by PerkinElmer 88
Jun 10, 2016: PerkinElmer and Sofie Biosciences extend and expand partnership 89
Jan 19, 2016: Agilent Technologies Extends Agreement with PerkinElmer on Bioanalyzer Chips 90
Appendix 91
Methodology 91
About GlobalData 91
Contact Us 91
Disclaimer 91

List of Tables
PerkinElmer Inc, Medical Equipment, Key Facts, 2016 2
PerkinElmer Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
PerkinElmer Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 7
PerkinElmer Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 8
PerkinElmer Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 9
PerkinElmer Inc, Deals By Market, 2011 to YTD 2017 10
PerkinElmer Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 11
Applied BioCode Expands Licensing Agreement with PerkinElmer for Barcoded Magnetic Bead Technology 13
PerkinElmer Expands Licensing Agreement With Tibco Software 14
PerkinElmer Enters Into Licensing Agreement With Tibco Software For Tibco Spotfire 15
PerkinElmer Enters Into Licensing Agreement With GenMark Diagnostics For Microfluidics Patent Portfolio 16
Fluidigm Amends Licensing Agreement with Caliper Life Sciences 17
Mobidiag Expand Agreement with Wallac 18
10X Genomics Enters into Agreement with PerkinElmer 19
OncoSec Medical Enters into Research Agreement with University of California and PerkinElmer 20
Sofie Biosciences and PerkinElmer Extends Partnership 21
PerkinElmer Enters into Distribution Agreement with Sebia 22
Good Start Genetics Enters Into Agreement With PerkinElmer To Provide GoodStart Select Carrier Screening Tests 23
Transgenomic Enters Into Co-Marketing Agreement With PerkinElmer For Oncology Diagnostic Test Portfolio 24
ViaCord Enters Into Agreement With Center for International Blood and Marrow Transplant Research For Stem Cell Therapy Research 25
TrovaGene Enters Into R&D Agreement With PerkinElmer Health Sciences 26
PerkinElmer Enters Into Agreement With National Center for Drug Screening 27
PerkinElmer Enters Into Co-Marketing Agreement With Verinata Health For Verifi Test 28
Perkinelmer Enters Into Co-Development Agreement With Massachusetts General Hospital 29
Integromics Enters Into Co-Development Agreement With Galician Foundation Of Genomic Medicine 30
DxTerity Diagnostics Enters Into Technology Integration Agreement With Caliper Life Sciences 31
PerkinElmer Enters Into Distribution Agreement With Rubicon Genomics 32
Roche Enters Into Distribution Agreement With PerkinElmer 33
Roche NimbleGen Enters Into Co-Marketing Agreement With Caliper Life Sciences 34
Caliper Life Sciences Enters Into Co-Development Agreement With HistoRx 35
Caliper Life Sciences Enters Into Co-Marketing Agreement With Covaris 36
PerkinElmer Enters Into Co-Development Agreement With Meyer Children’s Hospital of Florence 37
Caliper Life Sciences Enters Into An Agreement With Seegene 38
PerkinElmer Plans to Spin Out Diagnostics Business 39
PerkinElmer Raises USD552.3 Million in Public Offering of 1.875% Senior Notes Due 2026 40
PerkinElmer Completes Private Placement Of 5% Senior Notes Due 2021 For US$500 Million 42
Varex Imaging Acquires Medical Imaging Business of PerkinElmer 44
PerkinElmer to Acquire Tulip Diagnostics 45
PerkinElmer Acquires Vanadis Diagnostics 46
PerkinElmer Acquires Shanghai Haoyuan Biotech From Medigen Biotech For US$38 Million 47
PerkinElmer Completes Acquisition Of Caliper Life Sciences For US$600 Million 49
PerkinElmer Acquires Dexela 51
PerkinElmer Acquires Labtronics 52
PerkinElmer Acquires Geospiza 53
PerkinElmer Acquires Chemagen Biopolymer 54
PerkinElmer Inc, Key Competitors 56
PerkinElmer Inc, Key Employees 57
PerkinElmer Inc, Other Locations 58
PerkinElmer Inc, Subsidiaries 59
PerkinElmer Inc, Joint Venture 62

★海外企業調査レポート[PerkinElmer Inc (PKI)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Computer Services, Inc (CSVI):企業の財務・戦略的SWOT分析
    Computer Services, Inc (CSVI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Electrovaya Inc (EFL):企業の財務・戦略的SWOT分析
    Electrovaya Inc (EFL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Peel Environmental Ltd:電力:M&Aディール及び事業提携情報
    Summary Peel Environmental Ltd (Peel Environmental), a subsidiary of Peel Holdings (Management) Ltd, is a developer of infrastructures for the waste, mineral and environmental technology sectors. The company offers reprocess and re-manufacturing of waste materials with the use of energy. Its service …
  • Capita plc:企業の戦略・SWOT・財務情報
    Capita plc - Strategy, SWOT and Corporate Finance Report Summary Capita plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • The Hartford Financial Services Group, Inc.:企業のM&A・事業提携・投資動向
    The Hartford Financial Services Group, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Hartford Financial Services Group, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, det …
  • Star Gas Partners L.P.:企業の戦略・SWOT・財務情報
    Star Gas Partners L.P. - Strategy, SWOT and Corporate Finance Report Summary Star Gas Partners L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • TransMontaigne Product Services LLC-石油・ガス分野:企業M&A・提携分析
    Summary TransMontaigne Product Services LLC (TransMontaigne), a subsidiary of NGL Energy Partners LP, is an energy company, which carries out distribution and marketing of a wide range of petroleum products. The company markets several products including unbranded gasoline, diesel fuel, heating oil, …
  • Helix BioPharma Corp (HBP):企業の財務・戦略的SWOT分析
    Helix BioPharma Corp (HBP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • NBN Co Ltd:企業の戦略的SWOT分析
    NBN Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Tessi S.A. (TES):企業の財務・戦略的SWOT分析
    Tessi S.A. (TES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • E-CO Energi Holding AS:企業の戦略的SWOT分析
    E-CO Energi Holding AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Hitachi Metals, Ltd.:戦略・SWOT・企業財務分析
    Hitachi Metals, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Hitachi Metals, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Petroleum Development Oman LLC:企業の戦略的SWOT分析
    Petroleum Development Oman LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Southern Maryland Electric Cooperative Inc:発電所・企業SWOT分析
    Southern Maryland Electric Cooperative Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, infor …
  • Glu Mobile Inc (GLUU):企業の財務・戦略的SWOT分析
    Glu Mobile Inc (GLUU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Shenogen Pharma Group Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Shenogen Pharma Group Ltd (Shenogen) is a drug discovery and development company that develops therapeutics for cancer treatment. The company develops biologic drugs and small molecule targeted at the new estrogen receptor variant. It provides SNG-162 that is a small molecule naturally deriv …
  • GenePOC Inc:医療機器:M&Aディール及び事業提携情報
    Summary GenePOC Inc (GenePOC), a subsidiary of Debiopharm Group, is a medical device company that develops rapid molecular devices for providing targeted therapy. The company offers on-the-spot diagnostic devices for achieving optimal patient management. It offers diagnostic instruments based on a n …
  • CommonSpirit Health:企業の戦略的SWOT分析
    CommonSpirit Health - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Scottish and Southern Energy plc:企業の戦略・SWOT・財務分析
    Scottish and Southern Energy plc - Strategy, SWOT and Corporate Finance Report Summary Scottish and Southern Energy plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • NMDC Ltd:企業の戦略・SWOT・財務情報
    NMDC Ltd - Strategy, SWOT and Corporate Finance Report Summary NMDC Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆